The use of antibiotics in patients with myocardial infarction (MI) is not routinely recommended unless there is a clear indication, such as an active infection. However, in the past, some studies explored whether antibiotics could reduce cardiovascular complications in MI patients by targeting infections (e.g., Chlamydia pneumoniae) that might contribute to atherosclerosis. Here’s what the evidence shows:

1. Historical Context: Antibiotics and Atherosclerosis

• Some observational studies suggested a link between C. pneumoniae and coronary artery disease, leading to hypotheses that antibiotics (e.g., macrolides like azithromycin) might reduce inflammation and plaque instability.
• Clinical trials (e.g., WIZARD, ACES, PROVE-IT) tested macrolides (azithromycin, roxithromycin) or tetracyclines in MI patients but found no significant reduction in cardiovascular events.
• Some studies even suggested potential harm (e.g., increased mortality with azithromycin in high-risk patients, possibly due to arrhythmias or antibiotic resistance).

2. Current Guidelines

• No role for routine antibiotics in MI management (ACC/AHA/ESC guidelines).
• Antibiotics should only be used if there is a confirmed bacterial infection (e.g., pneumonia, infective endocarditis, or sepsis complicating MI).
• Exceptions:
• Infective endocarditis-related MI (rare, caused by septic emboli) requires targeted antibiotics.
• Post-MI complications (e.g., secondary infections after prolonged hospitalization or mechanical ventilation).

3. Risks of Unnecessary Antibiotics

• Antibiotic resistance (a major global health concern).
• QT prolongation & arrhythmias (some antibiotics, like macrolides and fluoroquinolones, increase this risk, especially in post-MI patients).
• Disruption of gut microbiota, potentially affecting recovery.

Conclusion

Antibiotics should not be used routinely in MI patients unless there is a clear infectious indication. Current evidence does not support their use for secondary prevention of coronary events. Always follow culture-guided therapy if an infection is suspected.